S Ruggieri Selected Research

Huntington Disease (Huntington's Disease)

6/2002	Striatal postsynaptic ultrastructural alterations following methylenedioxymethamphetamine administration.
8/2001	The prolonged cortical silent period in patients with Huntington's disease.
1/2001	Short-term effects of olanzapine in Huntington disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Ruggieri Research Topics

Disease

16	Parkinson Disease (Parkinson's Disease) 01/2009 - 01/2000
3	Multiple Sclerosis 06/2015 - 04/2014
3	Huntington Disease (Huntington's Disease) 06/2002 - 01/2001
2	Dyskinesias (Dyskinesia) 01/2009 - 03/2007
2	Hypothermia 06/2002 - 04/2001
1	Multiple Myeloma 03/2016
1	Relapsing-Remitting Multiple Sclerosis 04/2014
1	Atrophy 12/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2010
1	Substance-Related Disorders (Drug Abuse) 01/2009
1	Cognitive Dysfunction 10/2004
1	Larva Migrans (Cutaneous Larva Migrans) 05/2003
1	Infections 05/2003
1	Necrosis 06/2001
1	Parkinsonian Disorders (Parkinsonism) 04/2001
1	Movement Disorders (Movement Disorder) 12/2000
1	Hemolytic Anemia 08/2000
1	Multiple System Atrophy 01/2000
1	Melanoma (Melanoma, Malignant) 01/2000
1	Carcinoma (Carcinomatosis) 01/2000
1	Neoplasms (Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 01/2009 - 12/2000
4	Dopamine (Intropin)FDA LinkGeneric 01/2009 - 04/2001
4	Apomorphine FDA Link 06/2002 - 02/2001
3	Methamphetamine (Desoxyn)FDA LinkGeneric 10/2004 - 04/2001
2	Fas Ligand Protein (Fas Ligand)IBA 06/2015 - 05/2015
2	NeurotoxinsIBA 10/2004 - 04/2001
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2004 - 06/2002
2	Pramipexole (Mirapex)FDA LinkGeneric 04/2003 - 09/2002
2	ropinirole (Requip)FDA LinkGeneric 09/2002 - 03/2001
2	Dopamine Agonists (Dopamine Agonist)IBA 09/2002 - 03/2001
1	Bortezomib (Velcade)FDA Link 03/2016
1	Natalizumab (Tysabri)FDA Link 04/2014
1	CreatineIBA 12/2011
1	N-acetylaspartate (N-acetyl aspartate)IBA 12/2011
1	Riluzole FDA LinkGeneric 07/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2006
1	alpha-SynucleinIBA 01/2006
1	Pergolide (Permax)FDA Link 02/2005
1	AntibodiesIBA 05/2003
1	AntigensIBA 05/2003
1	Cabergoline FDA LinkGeneric 09/2002
1	Haloperidol (Haldol)FDA LinkGeneric 06/2002
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2001
1	Neuroprotective AgentsIBA 04/2001
1	Olanzapine (Zyprexa)FDA Link 01/2001
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2001
1	Biomarkers (Surrogate Marker)IBA 01/2001
1	Therapeutic UsesIBA 12/2000
1	nucleotidaseIBA 08/2000
1	pyrimidineIBA 08/2000
1	LipidsIBA 01/2000
1	Platelet Activating FactorIBA 01/2000
1	WEB 2086 (apafant)IBA 01/2000

Therapy/Procedure

4	Therapeutics 07/2010 - 09/2002
1	Transcranial Magnetic Stimulation 08/2001
1	Catheters 01/2000